Accuray Incorporated (ARAY) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Accuray Incorporated (ARAY) - Medical Equipment - Deals and Alliances Profile

Accuray Incorporated (ARAY) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Accuray Incorporated (ARAY) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
62 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Accuray Incorporated (Accuray) carries out the development, manufacture and sale of personalized treatment solutions for radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. The companys major products include CyberKnife robotic radiosurgery systems, TomoTherapy system and Radixact delivery treatment platform. Its flagship product, CyberKnife robotic radiosurgery system is designed to treat tumor anywhere in the body non-invasively with an accuracy of sub-millimeter.

Accuray Incorporated (ARAY) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials

  
Source:
Document ID
GDME69D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Accuray Incorporated, Medical Equipment, Deals By Year, 2010 to YTD 201652
Accuray Incorporated, Medical Equipment Deals By Type, 2010 to YTD 201671
Accuray Incorporated, Medical Equipment, Deals By Region, 2010 to YTD 201681
Accuray Incorporated, Medical Equipment, Deals By Market, 2010 to YTD 201691
Accuray Incorporated, Medical Equipment, Deals Summary, 2010 to YTD 2016101
Accuray Incorporated, Medical Equipment, Deal Details1117
  Partnerships111
    RaySearch Labs Terminates Licensing Agreement With TomoTherapy111
    Accuray Enters into Agreement with medPhoton121
    Accuray Enters into Agreement with RaySearch Lab131
    Accuray Enters into Co-Marketing Agreement with RaySearch Labs for RayCare141
    Accuray Enters into Agreement with MIM Software151
    Accuray Enters Into Co-Development Agreement With Erasmus161
    Accuray Enters Into Co-Development Agreement With German Cancer Research Center171
    Accuray Enters Into Co-Development Agreement With University of Heidelberg181
    Accuray Enters Into Co-Marketing Agreement With Siemens Healthcare For Robotic Radiosurgery System191
    Accuray Enters Into An Agreement With Siemens201
    TomoTherapy Enters Into Distribution Agreement With Nucletron211
  Debt Offering221
    Accuray Completes Private Placement Of Notes Due 2018 For US$100 Million221
    Accuray Completes Private Placement Of Convertible Senior Notes Due 2016 For US$100 Million231
  Acquisition241
    Accuray Acquires 90% Stake In Morphormics, Developer Of Medical Imaging Software, For US$6 Million242
    Accuray Completes Acquisition Of TomoTherapy262
Accuray Incorporated - Key Competitors281
Key Employees291
Locations And Subsidiaries302
  Head Office301
  Other Locations &Subsidiaries302
Recent Developments321
Financial Announcements321
Aug 17, 2016: Accuray Reports Fourth Quarter and Fiscal 2016 Financial Results322
Apr 26, 2016: Accuray Generates $105.3 Million in Third Quarter Revenues342
Jan 28, 2016: Accuray Generates $108.9 Million in Second Quarter Revenues362
Jan 11, 2016: Accuray Announces Preliminary Second Quarter Financial Results381
Oct 29, 2015: Accuray Generates 10% Year-Over-Year Gross Order Growth in First Quarter391
Aug 20, 2015: Accuray Generates 14% Year-Over-Year Gross Order Growth During Fourth Quarter402
Apr 30, 2015: Accuray Reports Financial Results for Third Quarter of Fiscal Year 2015422
Jan 27, 2015: Accuray Reports Financial Results for Second Quarter of Fiscal Year 2015442
Corporate Communications461
Oct 15, 2015: Kelly Londy Named Chief Operating Officer Of Accuray461
Sep 15, 2015: Kevin Waters Named Chief Financial Officer Of Accuray471
Product News481
Jan 14, 2016: Accuray Announces First CyberKnife System Installed in Qatar, Latvia481
Nov 05, 2015: First CyberKnife M6 System in Chile Installed at Fundacion Arturo Lopez Perez Cancer Institute491
Oct 13, 2015: Anova Cancer Care Treats 1,000th Prostate Cancer Patient with the CyberKnife System501
Jul 14, 2015: New TomoTherapy System Data Presented at Leading Scientific Industry Meeting511
Jun 04, 2015: CyberKnife Treatment Suggests that Stereotactic Ablative Radiotherapy Achieves Better Survival Rate for Early Lung Cancer521
Mar 17, 2015: LG Health receives first upgrade to its CyberKnife M6 System531
Mar 16, 2015: Cancer Treatment Centers of America in Philadelphia Offers Patients More Personalized, Precise Treatment with New TomoHDA TomoTherapy Machine541
Mar 02, 2015: First Patient Treatment with the CyberKnife M6 System and the InCise Multileaf Collimator Has Been Completed551
Feb 24, 2015: Lancaster General Health Receives First Commercial InCise Multileaf Collimator for the CyberKnife M6 System561
Clinical Trials571
Jun 04, 2015: CyberKnife Treatment Suggests that Stereotactic Ablative Radiotherapy Achieves Better Survival Rate for Early Lung Cancer571
Other Significant Developments581
Aug 21, 2015: Accuray Awarded Multi-System Order by 21st Century Oncology581
Apr 13, 2015: Accuray Establishes First TomoTherapy and CyberKnife System Education Centers in China591
Mar 05, 2015: Accuray and Christie InnoMed Sign Exclusive Sales Agent Agreements for Radiation Therapy Systems in Canada601
Feb 17, 2015: Class A User Licenses for Accuray Products Awarded to 16 Hospitals in China611
Appendix621
  Methodology621
  About GlobalData621
  Contact Us621
  Disclaimer621

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Accuray Incorporated (ARAY) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. May 04, 2025. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Accuray-Incorporated-ARAY-Medical-Equipment-Deals-and-Alliances-Profile-2148-9416>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Accuray Incorporated (ARAY) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Accuray-Incorporated-ARAY-Medical-Equipment-Deals-and-Alliances-Profile-2148-9416>
  
US$ 250.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research